Possibly, VEGF exerts a dual role in MS lesions: increased levels of VEGF can amplify vascular permeability in vessels and thus inflammation through glial cells during the acute phase of the disease, but can also stimulate the proliferation of neurons and their axons during the chronic phases of the disease [60]. The gene discussed is VEGFA; the disease is myeloid sarcoma.